<unk>  is an atypical antipsychotic that is FDA approved for the treatment of patients with schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include extrapyramidal symptoms and akathisia in Schizophrenia patients and extrapyramidal symptoms, akathisia, dyspepsia, vomiting, somnolence, and restlessness in patients with Bipolar mania (≥5%).
Cariprazine
Undecylenic acid
Phendimetrazine
Dimethylcarbate
Gedocarnil
Gadoterate
Vinyl bromide
Carmofur